Navigation Links
IVCC and Syngenta start project for novel insecticidal active ingredient for malaria control
Date:4/24/2009

IVCC and Syngenta, a leading innovator in insecticidal technology, have launched a project to develop a new insecticidal active ingredient for public health applications, as part of IVCC's strategy to break the impasse in development of mosquito control products. Improved and sustainable control of the insects that transmit disease is dependent upon development of new public health pesticides. However, since agrochemical insecticides are not targeted at mosquitoes, their profiles often do not match those required for public health application. This has led to a drought of new public health products.

This project aims to identify lead candidate compounds for a new active ingredient that is effective against adult mosquitoes, in particular against mosquito strains which have developed resistance to the existing pesticides. The Syngenta chemical collection contains more than 2.5 million distinct chemical substances acquired or synthesised over decades of agrochemical research. Researchers for the company believe that this collection could contain a number of potential candidates.

Syngenta has developed a novel screening process for identification of the optimal candidates from their collection. IVCC has collected together an Expert Scientific Advisory Committee which represents a "Who's Who" of the world of insecticide development and this group will review the data generated by the screening process with Syngenta experts to identify the best candidates that will be taken forward to the next phase.

Dr Tom McLean, Senior Executive Officer, explained the importance of IVCC's intervention: "The unique skills base within the agrochemical industry places them in an ideal position to develop new active ingredients for public health applications but the small market for public health pesticides simply could not support the high research and development costs of such a project.

"The role of the IVCC is to unlock the talent and enthusiasm of companies like Syngenta to enable them to take on huge research efforts for public health by absorbing the front end costs. We are delighted by the commitment that Syngenta has shown to this project."

"Syngenta has increased significantly its activities in the Vector Control area since 2008. We are really excited about this second project with IVCC," said Frdric Baur, Global Head Vector Control at Syngenta.

"It represents a key milestone in our long-term commitment to the fight against malaria and other mosquito transmitted diseases. It is an important part of our pledge to improve the health and quality of life in the rural communities. I am confident this new project will accelerate the development of new vector control products, which benefit communities where the need is greatest."


'/>"/>

Contact: Alan Hughes
a.p.hughes@liv.ac.uk
Liverpool School of Tropical Medicine
Source:Eurekalert

Related biology news :

1. Girls who begin dieting twice as likely to start smoking
2. Shape encoding may start in the retina
3. Freshman class sparks start-up company
4. Starting university may be hazardous to your health: study
5. Stowers Institutes Hawley Lab identifies factors responsible for restart of meiotic cycle
6. Starters orders for unique Ph.D.s in sport
7. NJIT start-up company NeuroTrax named best in show
8. Alzheimers starts earlier for heavy drinkers, smokers
9. No time to lose to start thinking sustainability
10. Trustee makes donation to start new solar energy research center at Rensselaer
11. Urea tanks on diesel trucks -- thats the law in the United States starting in 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2016)... -- --> --> Competitive ... Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance & Detection Systems ... security market and the continuing migration crisis in the ... has led visiongain to publish this unique report, which ... defence & security companies in the border security market ...
(Date:3/14/2016)... 2016 http://www.apimages.com ) - ... - Renvoi : image disponible via AP Images ... --> DERMALOG, le leader de ... lecteurs d,empreintes digitales pour l,enregistrement des réfugiés en ... pour produire des cartes d,identité aux réfugiés. DERMALOG ...
(Date:3/9/2016)... NEW YORK , March 9, 2016 ... current and future states of the RNA Sequencing (RNA ... in segments such as instruments, tools and reagents, data ... Analyze various segments of the RNA-Sequencing market such ... RNA-Sequencing services Identify the main factors affecting each segment ...
Breaking Biology News(10 mins):
(Date:5/5/2016)... , May 5, 2016  Why are two uber-successful ... Lorna Weir launching a new venture—yet going ... they believe that truly helping clients raise the value ... now demands a different type of collaboration. ... the pharmaceutical, biotechnology and medical device sectors. Elevate specializes ...
(Date:5/4/2016)... , May 4, 2016  Bayer today announced ... compound Stivarga ® (regorafenib) tablets for the ... has met its primary endpoint of a statistically ... RESORCE, evaluated the efficacy and safety of regorafenib ... after treatment with sorafenib. The safety and tolerability ...
(Date:5/3/2016)... India , May 3, 2016 /PRNewswire/ ... (DNA Chip (Genomics, Drug Discovery, Gene Expression) ... End user (Academics Institutes, Diagnostics Centers), Fabrication ... published by MarketsandMarkets, the market is expected ... from USD 7.63 Billion in 2015, growing ...
(Date:5/3/2016)... ... May 03, 2016 , ... Kerafast Inc., developers ... from laboratories across the globe, today announced the availability of a Zika virus ... research toward treatment and prevention measures for the Zika virus, the virus’s geographical ...
Breaking Biology Technology: